chr6-137154964-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_052962.3(IL22RA2):c.449C>T(p.Pro150Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000039 in 1,613,940 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_052962.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IL22RA2 | NM_052962.3 | c.449C>T | p.Pro150Leu | missense_variant | 5/7 | ENST00000296980.7 | |
IL22RA2 | NM_181309.2 | c.353C>T | p.Pro118Leu | missense_variant | 4/6 | ||
IL22RA2 | NM_181310.2 | c.353C>T | p.Pro118Leu | missense_variant | 4/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IL22RA2 | ENST00000296980.7 | c.449C>T | p.Pro150Leu | missense_variant | 5/7 | 1 | NM_052962.3 | ||
IL22RA2 | ENST00000349184.9 | c.353C>T | p.Pro118Leu | missense_variant | 4/6 | 1 | P1 | ||
IL22RA2 | ENST00000339602.3 | c.353C>T | p.Pro118Leu | missense_variant | 4/5 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152124Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251108Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135722
GnomAD4 exome AF: 0.0000369 AC: 54AN: 1461816Hom.: 0 Cov.: 31 AF XY: 0.0000426 AC XY: 31AN XY: 727214
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152124Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74300
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 30, 2022 | The c.449C>T (p.P150L) alteration is located in exon 5 (coding exon 4) of the IL22RA2 gene. This alteration results from a C to T substitution at nucleotide position 449, causing the proline (P) at amino acid position 150 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at